
China: Key Regulatory Changes from 2022 and Look Ahead to 2023
Get the latest on NMPA’s updated guidance for the clinical evaluation of medical devices.
Learn more about our China work.
Get the latest on NMPA’s updated guidance for the clinical evaluation of medical devices.
AdvaMed’s office in China sits at the forefront of helping our members navigate China’s large, fast-growing market for medical technologies.
Join us as we explore the advantages and intricacies to setting up a clinical study in China, India and Japan
Get the latest on NMPA’s updated guidance for the clinical evaluation of medical devices
Join us for our webinar with Sidley Austin and China Med Device for a comprehensive overview of China’s new regulatory policies.
先进医疗技术协会在全球积极倡导先进医疗技术发展,以促进人类生命健康与各国经济发展。
AdvaMed members work around the globe, so we do, too.
Achieve the highest levels of compliance with principles on consulting arrangements, training, education and other forms of communications.
Foreign manufacturers of COVID-19 products with FDA approval can get on China’s export white list.
The Chinese government announced a process to export particular devices without NMPA approval.